Anglo-French Drugs & Industries Ltd
- Current price
- — Per share
- Market cap
- ₹0 Cr Total valuation
- P/E ratio
- 0 Price to earnings
- Sector
- Healthcare & Pharmaceuticals Industry
About Anglo-French Drugs & Industries Ltd
Anglo-French Drugs & Industries Ltd operates in the Healthcare & Pharmaceuticals sector. Its shares are not listed on stock exchanges like NSE or BSE and are traded through private transactions.
Shares in private companies can offer exposure before a potential IPO. They carry higher risk than listed stocks, so proper research and a long-term outlook are important.
Anglo-French Drugs & Industries Ltd share FAQs
What is the Anglo-French Drugs & Industries Ltd share price today?
The Anglo-French Drugs & Industries Ltd share price is currently unavailable. Please check again later or contact the InvestShare team.
How can I buy Anglo-French Drugs & Industries Ltd shares?
Complete a simple KYC on InvestShare with your PAN, Aadhaar and demat account details, then place a buy request for Anglo-French Drugs & Industries Ltd. After confirmation and settlement, the shares are transferred to your demat account through an off-market transaction.
Is a demat account required to buy Anglo-French Drugs & Industries Ltd shares?
Yes, a demat account is required to hold Anglo-French Drugs & Industries Ltd shares. The shares are credited to your demat account through an off-market transfer.
Key data & fundamentals
About Anglo-French Drugs & Industries Ltd
Anglo-French Drugs & Industries Limited is a Public joined on 01 February 1923. It is delegated to a Non-govt organization and is enrolled at Registrar of Companies, Bangalore. Its approved offer capital is Rs. 20,000,000 and its settled up capital is Rs. 12,915,000. It is involved in the Manufacture of other synthetic items The Company produces and cycles nutrients, anti-epileptics, anti-oxidants, sleep-inducing agents, cold and cough preparations, protein food supplements, digestive enzymes, and calcium supplements AFDIL serves customers around the world. Anglo-French Drugs & Industries Limited's Annual General Meeting (AGM) was keep going hung on 29 September 2020 and according to records from the Ministry of Corporate Affairs (MCA), its asset report was kept going documented on 31 March 2020.
- Indicative price
- —
- Lot size
- 0
- 52 week high
- —
- 52 week low
- —
- Market cap
- ₹0 Cr
- No. of shares
- 11,30,000
- P/E ratio
- 0
- P/B ratio
- 0
- ROE
- 6.39 %
- Book value
- ₹1,195.84
- Face value
- ₹10
- ISIN
- —
- PAN
- AAACA9756E
Indicative price history
Financial statements
- Revenue · FY25
- 88 ₹ Cr ▼Down7%
- EBITDA · FY25
- -16.5 ₹ Cr ▼Down50%
- Profit before tax · FY25
- 8 ₹ Cr ▲Up167%
- Net profit (PAT) · FY25
- 8 ₹ Cr ▲Up167%
- Operating margin · FY25
- -18.75% ▼Down62%
- EPS · FY25
- ₹70.8 ▲Up173%
| Particulars | FY23 | FY24 | FY25 | YoY |
|---|---|---|---|---|
| Revenue | 103 | 95 | 88 | ▼Down7% |
| EBITDA | -40.5 | -11 | -16.5 | ▼Down50% |
| OPM (%) | -39.32 | -11.58 | -18.75 | ▼Down62% |
| PBT | 251 | -12 | 8 | ▲Up167% |
| PAT | 191 | -12 | 8 | ▲Up167% |
| EPS (₹) | 1,480.62 | -97.56 | 70.8 | ▲Up173% |
| Particulars | FY23 | FY24 | FY25 | YoY |
|---|---|---|---|---|
| Share capital | 1.29 | 1.23 | 1.13 | ▼Down8% |
| Reserves | 207 | 170 | 124 | ▼Down27% |
| Borrowings | 26 | 9 | 19 | ▲Up111% |
| Total assets | 273 | 220 | 192 | ▼Down13% |
| Total liabilities | 273 | 220 | 192 | ▼Down13% |
| Investments | 0.2 | 0.5 | 0.4 | ▼Down20% |
| Particulars | FY23 | FY24 | FY25 | YoY |
|---|---|---|---|---|
| CFO | 185 | -0.06 | 2 | ▲Up999+% |
| CF investing | -170 | 41 | 45 | ▲Up10% |
| CF financing | -12 | -47 | -46 | ▲Up2% |
| Net cash | 3 | -6.06 | 1 | ▲Up117% |
| Cash at end | 3.2 | -3.06 | 1.09 | ▲Up136% |